SPP1629 coordination project

SPP1629协调项目

• 批准号: 230781075
• 负责人: Professorin Dr. Heike Biebermann
• 金额: --
• 依托单位: Klinik für Endokrinologie und Stoffwechselerkrankungen
• 依托单位国家: 德国
• 项目类别: Priority Programmes
• 财政年份: 2012
• 资助国家: 德国
• 起止时间: 2011-12-31 至 2020-12-31
• 项目状态: 已结题
• 来源: https://gepris.dfg.de/gepris/projekt/230781075?language=en
• 关键词: SPP1629; coordination; project

This DFG priority program focuses on the question: WHAT DEFINES HEALTHY AND DISEASED THYROID FUNCTION? To answer this, THYROID TRANS ACT has established a network and coordination structure that integrates the efforts of leading thyroid research laboratories and centers in Germany. SPP1629 aims at translating findings in basic sciences to better treatment options for patients in the long run. In particular, we were successful in recruiting highly motivated and capable junior scientists who entered this emerging field of research. The consortium has also contributed to brain-gain in the field of endocrinology by facilitating the return of experienced German scientists from abroad. THYROID TRANS ACT provides a platform for connecting junior scientists, who are actively collaborating while being guided by senior researchers. These efforts are supported by focus meetings like the Annual Meeting of SPP1629, Arbeitstagung Experimentelle Schilddrüsenforschung and the Bregenz Summer School of Endocrinology. Individual career building is supported by an educational program for the young scientist that involves workshops, lab exchanges and a dual mentorship component ensuring supervision and feedback from different angles. THYROID TRANS ACT is highly collaborative as evidenced by numerous joint publications within the first funding period. Regular meetings take place every year, where progress is discussed and new project ideas are set into action by, e.g., defining SOPs, exchanging material, and sharing expertise in an open atmosphere. The results of SPP1629 are also presented as posters or oral presentations during meetings of the German Society of Endocrinology, the European Thyroid Association, and many more. THYROID TRANS ACT was honored by the attendance of the world-leading thyroidologists at its first International Conference in December 2014. Communication within the SPP1629 is achieved by our website (www.thyroidtransact.de) that provides information on the projects, members, news, and hot topics in thyroid research. Importantly, the website informs both, scientist and the interested lay-public about the results of the SPP1629 through its publications, while an internal area allows the members to share and exchange information. In the next funding period we will build on these important achievements and aim to support young scientists to establish themselves as independent researchers. In addition, we will continue to support mobility of returning thyroid researchers to Germany. We will promote formation of a long-lasting research network emerging from THYROID TRANS ACT. In particular, we aim to seed new consortia such as research groups or SFB that will act as well-connected hubs of thyroid research in Germany and internationally. Already now, the SPP1629 helped to internationally strengthen the position of German thyroidology. We will further pursue this goal by linking THYROID TRANS ACT to other international research consortia.

这个DFG优先计划的重点是这个问题：什么定义健康和患病的甲状腺功能？为了解决这个问题，THYROID TRANS ACT建立了一个网络和协调结构，整合了德国领先的甲状腺研究实验室和中心的努力。SPP1629旨在将基础科学的发现转化为长期患者更好的治疗选择。特别是，我们成功地招募了积极性高、能力强的年轻科学家，他们进入了这一新兴的研究领域。该联盟还通过促进有经验的德国科学家从国外回国，为内分泌学领域的人才培养做出了贡献。THYROID TRANS ACT为年轻科学家提供了一个平台，他们在高级研究人员的指导下积极合作。这些努力得到了SPP 1629年会、Arbeitstagung Experimentelle Schilddrüsenforschung和布雷根茨内分泌暑期学校等重点会议的支持。个人职业建设得到了年轻科学家教育计划的支持，该计划涉及研讨会，实验室交流和双重导师制，确保从不同角度进行监督和反馈。第一个资助期内的许多联合出版物证明，甲状腺移植法案是高度合作的。每年举行定期会议，讨论进展情况并将新的项目想法付诸行动，例如，在开放的氛围中定义SOP、交换材料和分享专业知识。SPP 1629的结果也在德国内分泌学会、欧洲甲状腺协会等会议期间以海报或口头报告的形式展示。THYROID TRANS ACT在2014年12月的第一次国际会议上获得了世界领先的甲状腺学家的出席。SPP 1629内部的交流是通过我们的网站（www.thyroidtransact.de）实现的，该网站提供了有关甲状腺研究的项目，成员，新闻和热门话题的信息。重要的是，该网站通过其出版物向科学家和感兴趣的普通公众通报SPP 1629的结果，而内部区域允许成员分享和交流信息。在下一个资助期内，我们将在这些重要成就的基础上，致力于支持年轻科学家成为独立的研究人员。此外，我们将继续支持返回德国的甲状腺研究人员的流动。我们将促进形成一个长期的研究网络，从甲状腺transs法案出现。特别是，我们的目标是建立新的联盟，如研究小组或SFB，这些联盟将成为德国和国际上甲状腺研究的良好联系中心。现在，SPP 1629已经帮助加强了德国甲状腺学在国际上的地位。我们将通过将《甲状腺移植法案》与其他国际研究财团联系起来，进一步实现这一目标。